DANSEY ROGER D — SEC Form 4 filings
SEC reporting owner CIK 1741836. 11 Form 4 filings on record with FilingPulse; latest filed 2026-05-21.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-05-13 to 2026-05-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | Director | 5 | — | — | 10 |
| BICYCLE THERAPEUTICS PLC (BCYC) | Director | 2 | — | — | 4 |
| Kronos Bio, Inc. (KRON) | Director | 2 | — | — | 4 |
| Nurix Therapeutics, Inc. (NRIX) | Director | 2 | — | — | 2 |
Form 4 filings — DANSEY ROGER D
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-21 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/award (A): 41,800 (derivative) @ $0 · Grant/award (A): 34,200 (derivative) @ $0 | EDGAR |
| 2026-05-15 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 31,250 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | BICYCLE THERAPEUTICS PLC (BCYC) | Grant/award (A): 3,032 @ $0 · Grant/award (A): 6,065 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-09-10 | 4 | BICYCLE THERAPEUTICS PLC (BCYC) | Grant/award (A): 12,500 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Kronos Bio, Inc. (KRON) | Disposition to issuer (D): 68,000 (derivative) @ $0 · Disposition to issuer (D): 5,868 (derivative) @ $0 · Disposition to issuer (D): 34,000 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 2,167 · Option exercise (M): 2,167 (derivative) @ $0 | EDGAR |
| 2024-06-26 | 4 | Kronos Bio, Inc. (KRON) | Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/award (A): 2,917 (derivative) @ $0 · Grant/award (A): 2,167 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 2,166 · Option exercise (M): 2,166 (derivative) @ $0 | EDGAR |
| 2024-05-13 | 4 | INOVIO PHARMACEUTICALS, INC. (INO) | Option exercise (M): 1,000 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1741836 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →